We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PreOmics Logo

PreOmics

PreOmics empowers its clients in life science to establish biological knowledge through efficient reliable solutions and workflows that set the standard for protein analysis. A trusted partner with deeply rooted scientific experience.

Latest Content

Abstract blue background with red blood cells representing proteomics research
Webinar

From Plasma to Proteome: Scalable and Reproducible Approaches for Biomarker Discovery

On-Demand
In this webinar, Dr. Sasha Singh and Duc Duong will highlight their respective research in addressing challenges in large-scale proteomics for biomarker discovery and identifying Alzheimer’s disease biomarkers.
Red and white blood cells in serum, with the Preomics logo at the top of the screen.
Webinar

Unlocking the Plasma Proteome: Advanced Profiling and Biomarker Discovery

On-Demand
Clinical blood analysis is crucial for monitoring health and diagnosing diseases, with blood-based biomarkers playing a key role.
proteomics Webinar featuring, Christof Lenz, PhD & Gregory Potts, PhD
Webinar

Transform Biomedicine and Drug Discovery Through Innovative Proteomics

On-Demand
In this webinar, hear from Christof Lenz, PhD, on tissue analysis in cardiac proteomics, and Greg Potts, PhD, on how chemoproteomics with DIA is accelerating drug discovery.
Preomics logo.
Product News

PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS

PreOmics GmbH announces the launch of its new ENRICHiST™ kits, which enable biologically unbiased enrichment of lower abundant plasma and serum proteins onto non-functionalized paramagnetic particles.
Scientific Machinery
App Note / Case Study

Unlock the Full Potential of FFPE Tissue in Proteomics

Formalin-fixed, paraffin-embedded (FFPE) tissue is a valuable resource in the retrospective proteomic analysis of clinical and non-clinical samples.
PreOmics Announces Closing of Series B Financing content piece image
Product News

PreOmics Announces Closing of Series B Financing

PreOmics GmbH has raised €13.5m in a Series B financing round provided by Bruker Corporation (Nasdaq: BRKR).
Advertisement